About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,709 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,709 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2921-2940 of 3,709 trials

CompletedA Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple SclerosisThe purpose of this two-center study is to examine the effectiveness of acupuncture treatments in addressing mobility deficits, sensorimotor impairment, and quality of life (QOL)…NCT03174379·New York, New York CompletedVR-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple SclerosisA prospective, randomized controlled single-blind trial will test the hypotheses that a 6- week intervention that combines treadmill training (TT) with virtual reality (VR)…NCT02427997·Urbana, Illinois and 1 other CompletedUse of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple SclerosisThe purpose of this study is to assess the effectiveness of two self-guided psychological treatments, Self-Hypnosis (HYP) and Mindfulness Meditation (MM) compared to Treatment as…NCT04688710·Seattle, Washington UnknownLow Fat Diet for Fatigue in MSA randomized, controlled pilot trial of a dietary intervention vs. wait-list control in patients with MS and fatigue for management of their fatigue.NCT03322982·Portland, Oregon CompletedFeasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple SclerosisAllogeneic human umbilical cord tissue-derived stem cells injected intravenously (IV) once per day for 7 days is a safe and will induce a therapeutic effect in multiple sclerosis…NCT02034188·Panama City

Related Searches

Data from ClinicalTrials.govTerms

UnknownmiR-142-3p as Potential Biomarker of Synaptopathy in MSInflammatory synaptopathy is a prominent pathogenic mechanism in multiple sclerosis (MS) and in its mouse model, which can cause excitotoxic damage by long-lasting excessive…NCT03999788·Pozzilli, Isernia

CompletedMitochondrial Dysfunction and Disease ProgressionWhile the last several years have seen great strides in the treatment of relapsing forms of MS, progressive MS, responsible for the majority of MS-related disability, lags far…NCT02549703·New York, New York

CompletedAdaptive Plasticity Following Rehabilitation in Multiple SclerosisMotor learning can induce significant changes in the human brain through neural plasticity processes, which play a crucial role in the brain functional reorganization in response…NCT03608527

UnknownDevelopment and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple SclerosisMultiple sclerosis (MS) is a progressive neurological disease that affects over 2.5 million people worldwide.NCT01303770·Petah Tikva

Not yet recruitingA Basket Study of CTA313 in Participants With Active Autoimmune DiseasesThe goal of the ALLNEW clinical trial is to learn if CTA313 UCART is safe and effective for patients with immune mediated disorders.NCT07783269

Active not recruitingA Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple SclerosisThis study will evaluate the efficacy and safety of ocrelizumab (Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including…NCT04035005·Washington D.C., District of Columbia and 154 others

RecruitingPolish Version Fatigue Severity ScaleFatigue is one of main symptoms in multiple sclerosis, amyotrophic lateral sclerosis and other diseases with profound effect on quality of life and professional and social…NCT06668649·Krakow, Lesser Poland Voivodeship and 1 other

UnknownInfluence of Socio-Economic Factor on Net Survival in Patients With Multiple Sclerosis in France ( ECOVIMUS).Background: In comparison to general population, persons with Multiple Sclerosis have a higher risk to premature death with an estimate reduced life expectancy from 7 to 14 years.NCT04028232·Caen, Normandy and 17 others

CompletedEvaluating Intervention Responsiveness in People With Multiple SclerosisThe purpose is to see how multiple sclerosis (MS) is associated with strength and sensation using MRI, in persons with MS. The investigators will also see whether exercise can…NCT01632293·Baltimore, Maryland

UnknownNeuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation ProgramThe purpose of the study is to determine the effect of an web-based intensive cognitive rehabilitation program in neuropsychological performance of a population of patients with…NCT02193906

CompletedRole of Virtual Reality in MS RehabilitationObjective: To investigate the role of virtual reality (VR) paired with robotic-assisted gait training (RAGT) compared with RAGT alone in patients with Multiple Sclerosis (MS).NCT02834533

CompletedPostural Control and Psychosocial Measures Associations in Multiple SclerosisBalance deficits, gait abnormalities, impaired cognitive function, psychological disturbances and disconnection from community are key characteristics of multiple sclerosis (MS).NCT06998147·Dokki

CompletedDetermine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy SubjectsThe goal of this clinical trial is to learn how Ozanimod drug can be administered to the healthy subjects via transdermal delivery system (TDS, patch) to achieve better drug…NCT06528665·Ampang, Selangor

CompletedRItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.A randomized phase 3 study comparing Rituximab with Dimethyl Fumarate in early Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome.NCT02746744·Borås and 16 others

RecruitingGait Adaptation StudyThis pilot study proposes a clinical trial to target treatment of sensorimotor and cognitive deficits in persons with Multiple Sclerosis (pwMS).NCT07660601·Newark, New Jersey

PreviousPage 147 of 186Next